Center for Cancer and Blood Disorders-Phoenix Children's Hospital — Phoenix, Arizona

Center for Cancer and Blood Disorders-Phoenix Children's Hospital is a clinical research site located in Phoenix, Arizona, United States 85016.

Crixeo Clinical Trials Trust Score: 88/100 (GOOD). This profile has not yet been claimed by the site owner.

Center for Cancer and Blood Disorders-Phoenix Children's Hospital has participated in 1 clinical trials.

Therapeutic areas: Recurrent or Refractory Pediatric Ependymoma.

Sponsors: OSI Pharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Phoenix

Browse all research sites in Arizona · View every site in Phoenix

Sponsor Feasibility Report

Trust Score: 88/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Center for Cancer and Blood Disorders-Phoenix Children's Hospital?

Center for Cancer and Blood Disorders-Phoenix Children's Hospital has a Crixeo Trust Score of 88/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Center for Cancer and Blood Disorders-Phoenix Children's Hospital conducted?

Center for Cancer and Blood Disorders-Phoenix Children's Hospital has 1 clinical trials on record. Their work covers Recurrent or Refractory Pediatric Ependymoma.

Is Center for Cancer and Blood Disorders-Phoenix Children's Hospital accredited by Crixeo Clinical Trials?

Center for Cancer and Blood Disorders-Phoenix Children's Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Center for Cancer and Blood Disorders-Phoenix Children's Hospital?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.